Stonepine Capital Management, LLC Adma Biologics, Inc. Transaction History

Stonepine Capital Management, LLC

$158 Billion
Q3 2024

A detailed history of Stonepine Capital Management, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 1,870,000 shares of ADMA stock, worth $32.5 Million. This represents 23.62% of its overall portfolio holdings.

Number of Shares

1,870,000

Previous 1,870,000 -0.0%

Holding current value

$32.5 Million

Previous $20.9 Billion 78.8%

% of portfolio

23.62%

Previous 19.07%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$5.98 - $11.18 $9.31 Million - $17.4 Million	-1,556,882 Reduced 45.43%	1,870,000 $20.9 Billion
Q1 2024 May 14, 2024	SELL	$4.4 - $6.74 $25.5 Million - $39.1 Million	-5,795,735 Reduced 62.84%	3,426,882 $22.6 Billion
Q4 2023 Feb 13, 2024	BUY	$3.08 - $4.52 $364,493 - $534,905	118,342 Added 1.3%	9,222,617 $41.7 Billion
Q3 2023 Nov 13, 2023	BUY	$3.47 - $4.61 $31.6 Million - $42 Million	9,104,275 New	9,104,275 $32.6 Billion
Q2 2023 Aug 11, 2023	BUY	$3.12 - $4.22 $3.53 Million - $4.78 Million	1,131,631 Added 14.77%	8,793,321 $32.4 Million
Q1 2023 May 12, 2023	BUY	$3.01 - $3.87 $2.17 Million - $2.79 Million	721,690 Added 10.4%	7,661,690 $25.4 Million
Q4 2022 Feb 14, 2023	BUY	$2.47 - $3.88 $4.79 Million - $7.53 Million	1,940,000 Added 38.8%	6,940,000 $26.9 Million
Q3 2022 Nov 10, 2022	SELL	$2.03 - $2.86 $4.06 Million - $5.72 Million	-2,000,000 Reduced 28.57%	5,000,000 $12.2 Million
Q2 2022 Aug 12, 2022	SELL	$1.43 - $2.2 $188,485 - $289,977	-131,808 Reduced 1.85%	7,000,000 $13.9 Million
Q1 2022 May 16, 2022	SELL	$1.28 - $1.83 $3.56 Million - $5.09 Million	-2,779,769 Reduced 28.05%	7,131,808 $13.1 Million
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.66 $10.8 Million - $16.5 Million	9,911,577 New	9,911,577 $14 Million
Q3 2018 Nov 13, 2018	SELL	$4.39 - $6.85 $3.65 Million - $5.7 Million	-831,731 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$4.39 - $5.44 $3.65 Million - $4.52 Million	831,731 New	831,731 $3.75 Million
Q1 2018 May 14, 2018	SELL	$3.21 - $5.21 $217,146 - $352,440	-67,647 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$2.06 - $3.24 $139,352 - $219,176	67,647	67,647 $217,000

Others Institutions Holding ADMA

# of Institutions

319

Shares Held

184M

Call Options Held

917K

Put Options Held

91.6K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.42B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.

Account

Stonepine Capital Management, LLC Adma Biologics, Inc. Transaction History